Bvf Inc Forte Biosciences, Inc. Transaction History

Bvf Inc

$3.15 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 14, 2023	BUY	$0.65 - $1.04 $1.94 Million - $3.1 Million	2,982,105 New	2,982,105 $1.97 Million
Q3 2021 Nov 15, 2021	SELL	$2.96 - $36.67 $1.75 Million - $21.7 Million	-591,811 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$31.5 - $42.5 $4 Million - $5.4 Million	-126,977 Reduced 17.67%	591,811 $19.9 Million
Q4 2020 Feb 12, 2021	SELL	$28.66 - $46.79 $1.68 Million - $2.75 Million	-58,765 Reduced 7.56%	718,788 $26.2 Million
Q3 2020 Nov 13, 2020	SELL	$14.71 - $50.69 $2.96 Million - $10.2 Million	-201,304 Reduced 20.57%	777,553 $37.7 Million
Q2 2020 Aug 14, 2020	BUY	$13.9 - $24.6 $13.6 Million - $24.1 Million	978,857 New	978,857 $14.3 Million

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$979,204
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.